Here, we hypothesize that the necessary genetic modifications for oncogenesis in the context of BRCA1/BRCA2 inactivation may arise from recurrent copy number alterations (CNAs) present in these neoplasms. This evidence concerns the gene BRCA1 and neoplasm.